EUVIMEDEUVIMED entdecken
Crossref

Sex Differences in Prescription, Initiation, and Discontinuation of Secondary Prevention Medications After Stroke

Lachlan L Dalli iD, Nadine E Andrew iD, Muideen T Olaiya iD, Dominique A Cadilhac iD, Joosup Kim, David Ung iD, Amanda G Thrift iD, Hoang T Phan iD, Seana Gall iD, Mark R Nelson iD, Monique F Kilkenny iD

Stroke · 2025

DOI: 10.1161/strokeaha.124.050207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2025. Verfasst von Lachlan L Dalli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health (L.L.D., M.T.O., D.A.C., J.K., A.G.T., S.G., M.F.K.)…. Hauptthemen laut MEDLINE: Secondary Prevention, Stroke, Sex Characteristics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Women less frequently receive secondary prevention medications at discharge poststroke than men. It is unclear whether similar sex differences exist in the long term poststroke, after accounting for age and clinical characteristics. We aimed to evaluate sex differences in medication prescription, initiation, and discontinuation poststroke or transient ischemic attack. METHODS: A retrospective cohort study using person-level linked data from the Australian Stroke Clinical Registry (42 hospitals; Victoria and Queensland; 2012–2016). We included all adults with first-ever ischemic stroke, intracerebral hemorrhage, or transient ischemic attack who survived >60 days post-discharge. For each major class of secondary prevention medication (antihypertensive, antithrombotic, or lipid lowering), we evaluated sex differences in prescription at hospital discharge, initiation within 60 days, and discontinuation within 2 years post-discharge. Sex differences were assessed using multivariable models, adjusted for sociodemographics and comorbidities. Where effect modification by age was found ( P interaction ≤0.05), age-specific odds ratios were reported. RESULTS: Among 8108 women (median age, 74.3 years) and 10 344 men (median age, 70.5 years) with first-ever stroke (≈8% intracerebral hemorrhage) or transient ischemic attack, women were less likely to be prescribed antihypertensive medications on discharge (odds ratio, 0.82 [95% CI, 0.74–0.91]). Women were less likely to initiate antihypertensive (odds ratio, 0.76 [95% CI, 0.69–0.84]) and antithrombotic (odds ratio, 0.89 [95% CI, 0.82–0.96]) medications within 60 days than men. While there was no overall difference in discontinuation between men and women, interactions were observed with age ( P interaction , all

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Secondary PreventionStrokeSex CharacteristicsHumansFemaleMaleAgedRetrospective StudiesMiddle AgedAged, 80 and overSex FactorsAntihypertensive AgentsIschemic Attack, TransientFibrinolytic AgentsRegistriesCohort StudiesAustraliaCerebral HemorrhageDrug Prescriptions

Stichwörter der Autor:innen

health equityischemic strokepharmacoepidemiologysecondary preventionsex characteristics

Substanzen

Antihypertensive AgentsFibrinolytic Agents

Autor:innen und Institutionen

  • Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health (L.L.D., M.T.O., D.A.C., J.K., A.G.T., S.G., M.F.K.), Monash University, Australia.
  • Department of Medicine, Peninsula Clinical School, Central Clinical School (N.E.A., D.U., M.F.K.), Monash University, Australia.
  • National Centre for Healthy Ageing, Peninsula Clinical School, Central Clinical School, Monash University, Australia (N.E.A., D.U.).
  • Stroke Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Australia (D.A.C., J.K.).
  • Menzies Institute for Medical Research, University of Tasmania, Australia (H.T.P., S.G., M.R.N.).
  • Centre for Child Development and Education, Menzies School of Health Research, Charles Darwin University, Australia (H.T.P.).

ORCID-Profile: Lachlan L Dalli, Nadine E Andrew, Muideen T Olaiya, Dominique A Cadilhac, David Ung, Amanda G Thrift, Hoang T Phan, Seana Gall, Mark R Nelson, Monique F Kilkenny

Zitieren

APA

Dalli, L. L., Andrew, N. E., Olaiya, M. T., Cadilhac, D. A., Kim, J., Ung, D., Thrift, A. G., Phan, H. T., Gall, S., Nelson, M. R., & Kilkenny, M. F. (2025). Sex Differences in Prescription, Initiation, and Discontinuation of Secondary Prevention Medications After Stroke. Stroke. https://doi.org/10.1161/strokeaha.124.050207

Vancouver

Dalli LL, Andrew NE, Olaiya MT, Cadilhac DA, Kim J, Ung D, et al. Sex Differences in Prescription, Initiation, and Discontinuation of Secondary Prevention Medications After Stroke. Stroke. 2025. doi:10.1161/strokeaha.124.050207

BibTeX
@article{Dalli2025,
  author = {Dalli, Lachlan L and Andrew, Nadine E and Olaiya, Muideen T and Cadilhac, Dominique A and Kim, Joosup and Ung, David and Thrift, Amanda G and Phan, Hoang T and Gall, Seana and Nelson, Mark R and Kilkenny, Monique F},
  title = {Sex Differences in Prescription, Initiation, and Discontinuation of Secondary Prevention Medications After Stroke},
  journal = {Stroke},
  year = {2025},
  doi = {10.1161/strokeaha.124.050207}
}
Kostenlos starten →